Open the map

ZoetisZTS

Big pharma · NYSE · USA

$73.08
Up 2.1% todayClose

Down 43.1% this year and −2.3% since July 2, against +10.7% for the life science sector since June 26. Zoetis buys from 1 mapped company.

Market cap
$29.9B
This year
−43.1%
1 year
−49.9%
P/E
11.4
P/S
3.1
P/B
9.5

Price vs the life science sector

since Jun 26ZTSLife science sector, equal weight
Zoetis (ZTS) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. ZTS: −2.3% from Jul 2, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−5%0%+5%+10%+15%Jun 26AugSepOct 8ZTS −2.3%Sector +10.7% Zoetis (ZTS) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. ZTS: −2.3% from Jul 2, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%Jun 26AugSepOct 8ZTS−2.3%Sector+10.7%

Supply chain

1 supplier
SUPPLIERS →→ CUSTOMERSCharles River Laboratories (CRL)CRLCharles River Labor…−0.8%None mappedZTSZoetis

Suppliers 1

Open the full chain →

About Zoetis

Spun out of Pfizer in 2013 to sell animal medicines and vaccines. Simparica handles parasites while Librela and Solensia treat pain, with pets on one side of the business and livestock on the other.

Theme exposure

Animal healthPetsDefensive growthPet medicineLivestock & foodDiagnostics

Products

  • Simparica (parasiticide)
  • Librela / Solensia (pain)
  • Vaccines

Competitors

  • Merck Animal Health
  • Elanco
  • Boehringer Ingelheim

Risks

  • Pet spending is cyclical
  • Generic competition

Same segment: Big pharma

Large, diversified pharmaceutical groups with broad portfolios across therapeutic areas. Segment 2 of 8 in the Medicine, pharma & life science value chain.

Johnson & JohnsonJNJ−0.8%AbbVieABBV+0.4%Merck & Co.MRK−0.3%PfizerPFE−0.6%Bristol Myers SquibbBMY−0.2%

Compare ZTS

Side by side with the largest companies in the same segment.

ZTS vs JNJZTS vs ABBVZTS vs MRKZTS vs PFEZTS vs BMY

See where Zoetis sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →